152 related articles for article (PubMed ID: 8082506)
1. CCK-receptor antagonists proglumide and loxiglumide stimulate bile flow and biliary glutathione excretion.
Sztefko K; Li P; Ballatori N; Chey WY
Dig Dis Sci; 1994 Sep; 39(9):1974-80. PubMed ID: 8082506
[TBL] [Abstract][Full Text] [Related]
2. A cholecystokinin receptor antagonist, loxiglumide, stimulates biliary secretion in conscious rats.
Watanabe N; Otsuki M
Eur J Pharmacol; 1994 Nov; 264(3):331-6. PubMed ID: 7698173
[TBL] [Abstract][Full Text] [Related]
3. Impairment of hepatic transport processes in perfused rat liver by the specific CCK receptor antagonist loxiglumide.
Beckh K; Dirks A; Koop I; Koop H; Adler G
Res Exp Med (Berl); 1997; 197(3):125-35. PubMed ID: 9406280
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters.
Ogura Y; Matsuda S; Itho M; Sasaki H; Tanigawa K; Shimomura M
World J Surg; 2002 Mar; 26(3):359-65. PubMed ID: 11865375
[TBL] [Abstract][Full Text] [Related]
5. Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress.
Lauterburg BH; Smith CV; Hughes H; Mitchell JR
J Clin Invest; 1984 Jan; 73(1):124-33. PubMed ID: 6690473
[TBL] [Abstract][Full Text] [Related]
6. The effect of cholecystokinin-receptor antagonists on cholecystokinin-stimulated bile flow in dogs.
Westfall S; Andrus C; Schlarman D; Kaminski DL
Surgery; 1991 Mar; 109(3 Pt 1):294-300. PubMed ID: 2000561
[TBL] [Abstract][Full Text] [Related]
7. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
8. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.
Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H
Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479
[TBL] [Abstract][Full Text] [Related]
9. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
[TBL] [Abstract][Full Text] [Related]
11. Glutathione as a primary osmotic driving force in hepatic bile formation.
Ballatori N; Truong AT
Am J Physiol; 1992 Nov; 263(5 Pt 1):G617-24. PubMed ID: 1443136
[TBL] [Abstract][Full Text] [Related]
12. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
[TBL] [Abstract][Full Text] [Related]
13. Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats.
Ishizaki K; Kinbara S; Kawamura M; Kimura K; Shiratori K; Takeuchi T
Pancreas; 2003 Jan; 26(1):87-91. PubMed ID: 12499923
[TBL] [Abstract][Full Text] [Related]
14. CCK receptor antagonist loxiglumide alters uptake of CCK in perfused liver and pancreatic acini of the rat.
Beckh K; Göke R; Ruff W; Koop I; Arnold R; Adler G
Digestion; 1991; 48(2):98-103. PubMed ID: 1868975
[TBL] [Abstract][Full Text] [Related]
15. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
[TBL] [Abstract][Full Text] [Related]
16. Elevation of feed intake in parasite-infected lambs by central administration of a cholecystokinin receptor antagonist.
Dynes RA; Poppi DP; Barrell GK; Sykes AR
Br J Nutr; 1998 Jan; 79(1):47-54. PubMed ID: 9505802
[TBL] [Abstract][Full Text] [Related]
17. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
[TBL] [Abstract][Full Text] [Related]
18. [Effects of cholecystokinin, gastrin and proglumide on bile secretion in rats].
Zhang J; Liu Y; Xu QZ
Sheng Li Xue Bao; 1990 Apr; 42(2):175-80. PubMed ID: 2374937
[TBL] [Abstract][Full Text] [Related]
19. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
